Novel therapeutic options for Dravet and Lennox-Gastaut syndrome.

Published by on

Related Posts

Medical

The relationship between cannabis and schizophrenia: a genetically informed perspective

Addiction. 2021 May 5. doi: 10.1111/add.15534. Online ahead of print. ABSTRACT BACKGROUND AND AIMS: While epidemiologic studies support a role for heavy, high-potency cannabis use on first episode psychosis, genetic models of causation suggest reverse Read more…

Medical

Structural correlates of sensorimotor dysfunction in heavy cannabis users

Addict Biol. 2021 May 5:e13032. doi: 10.1111/adb.13032. Online ahead of print. ABSTRACT Sensorimotor dysfunction has been previously reported in persons with cannabis dependence. Such individuals can exhibit increased levels of neurological soft signs (NSS), particularly Read more…

Medical

A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects

Clin Pharmacol Drug Dev. 2021 May 5. doi: 10.1002/cpdd.950. Online ahead of print. ABSTRACT This pharmacokinetic (PK) drug-interaction trial investigated the effects of repeated dosing of a plant-derived pharmaceutical formulation of highly purified cannabidiol (CBD; Read more…

error: Content is protected !!